The Metabolic Syndrome - from Insulin Resistance to Obesity and Diabetes

被引：73

作者：

Gallagher, Emily Jane ^{[3
]}

LeRoith, Derek ^{[3
]}

Karnieli, Eddy ^{[1
,2
]}

机构：

[1] Technion Israel Inst Technol, Rambam Med Ctr, Inst Endocrinol Diabet & Metab, IL-31096 Haifa, Israel

[2] Technion Israel Inst Technol, RB Rapaport Fac Med, IL-31096 Haifa, Israel

[3] Mt Sinai Med Ctr, Dept Med, Div Endocrinol Diabet & Bone Dis, New York, NY 10029 USA

来源：

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA | 2008年 / 37卷 / 03期

关键词：

D O I：

10.1016/j.ecl.2008.05.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In today's society with the escalating levels of obesity, diabetes, and cardiovascular disease, the metabolic syndrome is receiving considerable attention and is the subject of much controversy. Greater insight into the mechanism(s) behind the syndrome may improve our understanding of how to prevent and best manage this complex condition.

引用

页码：559 / +

页数：22

共 117 条

[81] Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation [J].

Paz, K ;

Hemi, R ;

LeRoith, D ;

Karasik, A ;

Elhanany, E ;

Kanety, H ;

Zick, Y .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (47) :29911-29918

[82] Control of gene expression by fatty acids [J].

Pégorier, JP ;

Le May, C ;

Girard, J .

JOURNAL OF NUTRITION, 2004, 134 (09) :2444S-2449S

[83] Use of lifestyle changes treatment plans and drug therapy in controlling cardiovascular and metabolic risk factors [J].

Pi-Sunyer, F. Xavier .

OBESITY, 2006, 14 :135S-142S

[84]

Pi-Sunyer FX, 1998, AM J CLIN NUTR, V68, P899

[85] Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss - An update of the 1997 American Heart Association Scientific Statement on obesity and heart disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism [J].

Poirier, P ;

Giles, TD ;

Bray, GA ;

Hong, YL ;

Stern, JS ;

Pi-Sunyer, FX ;

Eckel, RH .

CIRCULATION, 2006, 113 (06) :898-918

[86] Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1α interaction [J].

Puigserver, P ;

Rhee, J ;

Donovan, J ;

Walkey, CJ ;

Yoon, JC ;

Oriente, F ;

Kitamura, Y ;

Altomonte, J ;

Dong, HJ ;

Accili, D ;

Spiegelman, BM .

NATURE, 2003, 423 (6939) :550-555

[87] ROLE OF INSULIN RESISTANCE IN HUMAN-DISEASE (SYNDROME-X) - AN EXPANDED DEFINITION [J].

REAVEN, GM .

ANNUAL REVIEW OF MEDICINE, 1993, 44 :121-131

[88] ROLE OF INSULIN RESISTANCE IN HUMAN-DISEASE [J].

REAVEN, GM .

DIABETES, 1988, 37 (12) :1595-1607

[89] The obesity pandemic:: Where have we been and where are we going? [J].

Roth, J ;

Qiang, XL ;

Marbán, SL ;

Redelt, H ;

Lowell, BC .

OBESITY RESEARCH, 2004, 12 :88S-101S

[90] Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study [J].

Rutter, MK ;

Meigs, JB ;

Sullivan, LM ;

D'Agostino, RB ;

Wilson, PW .

DIABETES, 2005, 54 (11) :3252-3257

← 3 4 5 6 7 8 9 10 11 12 →